These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

642 related items for PubMed ID: 25487315

  • 1. Selected extracellular microRNA as potential biomarkers of multiple sclerosis activity--preliminary study.
    Kacperska MJ, Jastrzebski K, Tomasik B, Walenczak J, Konarska-Krol M, Glabinski A.
    J Mol Neurosci; 2015 May; 56(1):154-63. PubMed ID: 25487315
    [Abstract] [Full Text] [Related]

  • 2. Differential microRNA expression in blood in multiple sclerosis.
    Søndergaard HB, Hesse D, Krakauer M, Sørensen PS, Sellebjerg F.
    Mult Scler; 2013 Dec; 19(14):1849-57. PubMed ID: 23773985
    [Abstract] [Full Text] [Related]

  • 3. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
    Gandhi R, Healy B, Gholipour T, Egorova S, Musallam A, Hussain MS, Nejad P, Patel B, Hei H, Khoury S, Quintana F, Kivisakk P, Chitnis T, Weiner HL.
    Ann Neurol; 2013 Jun; 73(6):729-40. PubMed ID: 23494648
    [Abstract] [Full Text] [Related]

  • 4. Plasmatic microRNA as Potential Biomarkers of Multiple Sclerosis: Literature Review.
    Kacperska MJ, Walenczak J, Tomasik B.
    Adv Clin Exp Med; 2016 Jun; 25(4):775-9. PubMed ID: 27629854
    [Abstract] [Full Text] [Related]

  • 5. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
    Honardoost MA, Kiani-Esfahani A, Ghaedi K, Etemadifar M, Salehi M.
    Gene; 2014 Jul 10; 544(2):128-33. PubMed ID: 24792898
    [Abstract] [Full Text] [Related]

  • 6. Micro-RNA-96 and interleukin-10 are independent biomarkers for multiple sclerosis activity.
    Sedeeq MS, El-Nahrery EMA, Shalaby N, Hussein M, Shehata H, El Aal RA, Abdel Ghaffar NF, Mohamed MM.
    J Neurol Sci; 2019 Aug 15; 403():92-96. PubMed ID: 31238191
    [Abstract] [Full Text] [Related]

  • 7. Association between circulating MicroRNAs (hsa-miR-92a-1* and hsa-miR-454) and multiple sclerosis phenotypes and activity status.
    Moharram AA, Amer HA, Bakr SI, Fouad NT, Zamzam D, M R.
    Egypt J Immunol; 2022 Apr 15; 29(2):10-18. PubMed ID: 35436050
    [Abstract] [Full Text] [Related]

  • 8. Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.
    Regev K, Healy BC, Khalid F, Paul A, Chu R, Tauhid S, Tummala S, Diaz-Cruz C, Raheja R, Mazzola MA, von Glehn F, Kivisakk P, Dupuy SL, Kim G, Chitnis T, Weiner HL, Gandhi R, Bakshi R.
    JAMA Neurol; 2017 Mar 01; 74(3):275-285. PubMed ID: 28114622
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression.
    Yang G, Yang L, Wang W, Wang J, Wang J, Xu Z.
    Gene; 2015 May 10; 562(1):138-44. PubMed ID: 25725128
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases.
    Sharaf-Eldin WE, Kishk NA, Gad YZ, Hassan H, Ali MAM, Zaki MS, Mohamed MR, Essawi ML.
    J Neurol Sci; 2017 Dec 15; 383():188-198. PubMed ID: 29246612
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.